02.02 Pharmaceutical disruption of B2GPI CXCL4 complex using computationally designed oligopeptides

Markos D Patsouras; Eleni D Papakonstantinou; Elias E Eliopoulos; Panayiotis G Vlachoyiannopoulos

doi:10.1136/annrheumdis-2016-211050.2

Article info

New players and novel targets in inflammation

02.02 Pharmaceutical disruption of B2GPI CXCL4 complex using computationally designed oligopeptides

Authors

Markos D Patsouras 1Department of Pathophysiology, Medical school, National and Kapodistrian University of Athens, Greece PubMed articles Google scholar articles
Eleni D Papakonstantinou 2Department of Biotechnology, Agricultural University of Athens, Greece PubMed articles Google scholar articles
Elias E Eliopoulos 2Department of Biotechnology, Agricultural University of Athens, Greece PubMed articles Google scholar articles
Panayiotis G Vlachoyiannopoulos 1Department of Pathophysiology, Medical school, National and Kapodistrian University of Athens, Greece PubMed articles Google scholar articles

Citation

Patsouras MD, Papakonstantinou ED, Eliopoulos EE, et al

02.02 Pharmaceutical disruption of B2GPI CXCL4 complex using computationally designed oligopeptides

Annals of the Rheumatic Diseases 2017;76:A8-A9.

Publication history

First published March 1, 2017.

Online issue publication

January 09, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password